Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer
…, T Amundsen, S Sørhaug, H Hjelde, S Kaasa… - Acta …, 2015 - Taylor & Francis
Background. Sarcopenia is a defining feature of cancer cachexia associated with physical
decline, poor quality of life and poor prognosis. Thus, maintaining muscle mass is an …
decline, poor quality of life and poor prognosis. Thus, maintaining muscle mass is an …
[HTML][HTML] Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling
…, U Nonstad, PR Romundstad, F Skorpen, S Sørhaug… - Scientific reports, 2017 - nature.com
… It is however, to be noted that, in vivo, the autophagy-inducing factor(s) from the cancer cells
could be accompanied by other cancer-associated conditions to cause cachexia. Although …
could be accompanied by other cancer-associated conditions to cause cachexia. Although …
New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss
…, BHL Tan, TS Solheim, S Sørhaug… - Journal of cachexia …, 2017 - Wiley Online Library
Background Cachexia affects the majority with advanced cancer. Based on current demographic
and clinical factors, it is not possible to predict who will develop cachexia or not. Such …
and clinical factors, it is not possible to predict who will develop cachexia or not. Such …
PET/MR brain imaging: evaluation of clinical UTE-based attenuation correction
…, A Karlberg, PE Goa, A Håberg, S Sørhaug… - European journal of …, 2015 - Springer
… , and there is no direct relationship between a tissue’s MR signal and its electron density [3]. …
Proper segmentation of the skull’s bone and tissue/air interfaces is of vital importance for …
Proper segmentation of the skull’s bone and tissue/air interfaces is of vital importance for …
Chronic inhalation of carbon monoxide: effects on the respiratory and cardiovascular system at doses corresponding to tobacco smoking
S Sørhaug, S Steinshamn, OG Nilsen, HL Waldum - Toxicology, 2006 - Elsevier
… All sections were finally counterstained with haematoxylin for 6 s. … + S weight in the CO
exposed versus the control group (556 ± 33 mg versus 510 ± 14 mg, n = 4 versus 2, respectively). …
exposed versus the control group (556 ± 33 mg versus 510 ± 14 mg, n = 4 versus 2, respectively). …
[HTML][HTML] Ectonucleotidase CD39 and checkpoint signalling receptor programmed death 1 are highly elevated in intratumoral immune cells in non–small-cell lung …
A Tøndell, SGF Wahl, AM Sponaas, S Sørhaug… - Translational …, 2020 - Elsevier
… , and possibly combinational regimes, an immune response profile in NSCLC may provide
a means to target immunotherapy to the specific immunosuppressive mechanism(s) active in …
a means to target immunotherapy to the specific immunosuppressive mechanism(s) active in …
Measurement of health-related quality of life during chemotherapy–the importance of timing
…, T Amundsen, HH Hjelde, S Kaasa, S Sørhaug… - Acta …, 2017 - Taylor & Francis
Background: Side effects of chemotherapy may occur at different time-points in the treatment
cycle, and the exact assessment time relative to chemotherapy may affect HRQoL scores. …
cycle, and the exact assessment time relative to chemotherapy may affect HRQoL scores. …
[HTML][HTML] Medical complexity and time to lung cancer treatment–a three-year retrospective chart review
T Stokstad, S Sørhaug, T Amundsen… - BMC health services …, 2017 - Springer
… Patients were classified as “hospitalized” when admitted to the hospital due to the patient’s
condition at start of diagnostic work-up, otherwise they were classified as “outpatient”. …
condition at start of diagnostic work-up, otherwise they were classified as “outpatient”. …
[HTML][HTML] Analysis of intra-tumoral macrophages and T cells in non-small cell lung cancer (NSCLC) indicates a role for immune checkpoint and CD200-CD200R …
…, Y Subbannayya, SGF Wahl, A Flatberg, S Sørhaug… - Cancers, 2021 - mdpi.com
… The unit’s expertise in flow cytometry and sorting has been pivotal for this study. Claire
Louet from IKOM/NTNU provided valuable help with RNA isolation. We are very grateful for the …
Louet from IKOM/NTNU provided valuable help with RNA isolation. We are very grateful for the …
[HTML][HTML] Reasons for prolonged time for diagnostic workup for stage I-II lung cancer and estimated effect of applying an optimized pathway for diagnostic procedures
T Stokstad, S Sørhaug, T Amundsen… - BMC Health Services …, 2019 - Springer
… the result of a procedure was documented in the patient’s medical record; g) the date a
treatment decision was documented in the patient’s medical record (“Treatment decision”); h) the …
treatment decision was documented in the patient’s medical record (“Treatment decision”); h) the …